Norgine Ventures logo

Norgine Ventures

Europe, Hillingdon, United Kingdom, Uxbridge

Description

Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies.

Investor Profile

Norgine Ventures has made 27 investments, with 0 in the past 12 months and 59% as lead.

Stage Focus

  • Series Unknown (44%)
  • Debt Financing (22%)
  • Series B (7%)
  • Seed (7%)
  • Convertible Note (7%)
  • Post Ipo Debt (4%)
  • Post Ipo Equity (4%)
  • Series A (4%)

Country Focus

  • France (19%)
  • United Kingdom (15%)
  • Spain (11%)
  • The Netherlands (11%)
  • United States (11%)
  • Israel (11%)
  • Germany (7%)
  • Switzerland (4%)
  • Sweden (4%)
  • Denmark (4%)

Industry Focus

  • Health Care
  • Medical Device
  • Medical
  • Biotechnology
  • Health Diagnostics
  • Manufacturing
  • Information Technology
  • Life Science
  • Computer
  • Video
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Norgine Ventures frequently co-invest with?

Fraser
Europe, England, United Kingdom, London
Co-Investments: 1
MD
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Claret Capital Partners
Europe, England, United Kingdom, London
Co-Investments: 2
UNIQA Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 1
TA Ventures
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
LBO France
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Charles River Laboratories International
North America, Massachusetts, United States, Wilmington
Co-Investments: 1
CB
North America, California, United States, Chatsworth
Co-Investments: 1
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
NC
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Norgine Ventures often collaborate with?

Shared Deals: 1
RD
North America, California, United States, Los Angeles
Shared Deals: 1
JP
North America, Virginia, United States, Great Falls
Shared Deals: 1

What are some of recent deals done by Norgine Ventures?

Lunaphore

Lausanne, Vaud, Switzerland

Lunaphore is a life sciences company that is creating technologies to enable spatial biology in all laboratories.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceMedical Device
Debt FinancingMar 23, 2023
Amount Raised: $10,908,123
Sirius Medical

Eindhoven, Noord-Brabant, The Netherlands

Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment.

Health CareMedicalMedical Device
Series BMar 21, 2023
Amount Raised: $12,927,830
Magentiq Eye Ltd

Haifa, Hefa, Israel

Magentiq Eye LTD develops the MAGENTIQ-COLO™ System for Automatic Polyp Detection and Analysis during the Colonoscopy Procedures

ComputerHealth CareHealth DiagnosticsInformation TechnologyVideo
Convertible NoteAug 16, 2022
Amount Raised: $600,000
Impress

Barcelona, Catalonia, Spain

Impress is a developer of orthodontic technology that offers invisible aligners.

DentalHealth CareMedical
Series BJul 11, 2022
Amount Raised: $125,000,000
Inovus Medical

St. Helens, Staffordshire, United Kingdom

The perfect package for any general surgical trainees or residents.

Life ScienceMedicalMedical DevicePharmaceutical
Series UnknownMay 20, 2022
Amount Raised: $7,000,000
Magentiq Eye Ltd

Haifa, Hefa, Israel

Magentiq Eye LTD develops the MAGENTIQ-COLO™ System for Automatic Polyp Detection and Analysis during the Colonoscopy Procedures

ComputerHealth CareHealth DiagnosticsInformation TechnologyVideo
Convertible NoteJul 31, 2021
Amount Raised: $1,800,000
Alesi Surgical

Cardiff, Cardiff, United Kingdom

Alesi Surgical develops and commercialises products that improve the safety

BiotechnologyHealth CareTherapeutics
Series UnknownJul 20, 2021
Amount Raised: $12,815,409
ImaginAb

Inglewood, California, United States

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

BiotechnologyClinical TrialsHealth CareHealth Diagnostics
Series UnknownJun 3, 2021
Amount Raised: $12,800,000
PathoQuest

Paris, Ile-de-France, France

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

BiotechnologyHealth CareTherapeutics
Series UnknownSep 6, 2019
Amount Raised: $8,903,629
Impress

Barcelona, Catalonia, Spain

Impress is a developer of orthodontic technology that offers invisible aligners.

DentalHealth CareMedical
SeedJan 1, 2019